Lucas Ward Stock Analyst Profile - Ascendiant Capital Research Coverage - Stocknear

Lucas Ward

Stock Analyst at Ascendiant Capital

(2.09)
# 3285
Out of 5,506 analysts
24
Total ratings
Success rate
Average return

8 Stocks

Name Action PT Current % Upside Ratings Updated
HSCS HeartSciences
Maintains: Buy
15 9
3.7 143.24% 3 Oct 1, 2025
ACON Aclarion
Maintains: Strong Buy
20 22
7.57 190.62% 4 Sep 19, 2025
VVOS Vivos Therapeutics
Maintains: Strong Buy
7 7
3.19 103.76% 4 Sep 9, 2025
SXTP 60 Degrees
Maintains: Buy
7 3
1.4 114.29% 3 Sep 3, 2025
LIQT LiqTech Internationa...
Maintains: Strong Buy
4 4
2.85 26.32% 5 Jun 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
3 1
n/a n/a 2 Aug 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
3375 2700
1.51 178707.95% 2 Jul 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
2160
n/a n/a 1 Mar 6, 2023